BEAULEA

Welcome to the Brand page for “BEAULEA”, which is offered here for In the statement, lines 4 through 19, should be deleted, and pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system should be inserted.;[ pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics ] * pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system *;.

Its status is currently believed to be active. Its class is unavailable. “BEAULEA” is believed to be currently owned by “NOVARTIS AG”.


Owner:
NOVARTIS AG
Owner Details
Description:
In the statement, lines 4 through 19, should be deleted, and Pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system should be inserted.;[ Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics ] * Pharmaceutical preparations for the treatment of diseases and disorders of the respiratory system *;
Categories: STATEMENT